Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Will Ince
Institutions:
University of Cambridge,
Royal Devon & Exeter NHS Foundation Trust,
Cambridge University Hospitals NHS Foundation Trust,
Addenbrooke's Hospital
Observed institutions:
University of Cambridge,
Royal Devon & Exeter NHS Foundation Trust,
Cambridge University Hospitals NHS Foundation Trust,
Addenbrooke's Hospital
ORCID:
0000-0002-2122-7760
Observed ORCID:
0000-0002-2122-7760
OpenAlex ID:
A5125897068
Amivantamab in HPV-unrelated recurrent/metastatic head and neck squamous cell cancer after disease progression on immune checkpoint inhibitor and chemotherapy: Pivotal results from the phase 1b/2 OrigAMI-4 study.
2026
·
Barbara Burtness
, Kevin Joseph Harrington
, et al.
·
Journal of Clinical Oncology
·
1
Precision Immunotherapy: Revolutionizing Cancer Treatment With Targeted Innovations
2026
·
Myung-Ju Ahn
, Bernadett Szabados
, et al.
·
American Society of Clinical Oncology Educational Book
·
1
Machine learning prognostication in nasopharyngeal carcinoma: a european multicentre analysis of survival and risk of second malignancy
2026
·
Irina Maria Pușcaș
, Anda Gata
, et al.
·
European Archives of Oto-Rhino-Laryngology
Survival determinants and treatment patterns in a European multi-center cohort of patients with nasopharyngeal carcinoma
2026
·
Irina Maria Pușcaș
, Anda Gâta
, et al.
·
Medicine and Pharmacy Reports
PDF
Human 3D epithelioids enable continuous long-term clonal evolution studies across multiple epithelial tissues
2026
·
Ines S Ferreira
, Alberto Pradilla-Dieste
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Germline HLA class II diversity as a predictor of survival selectively in MHC-silenced gliomas.
2026
·
Om H. Gandhi
, Michael E. Bryan
, et al.
·
Journal of Clinical Oncology
PDF
Off-target HLA matches for prediction of response in personalised cancer vaccines: A multi-trial retrospective analysis.
2026
·
Om H. Gandhi
, Michael E. Bryan
, et al.
·
Journal of Clinical Oncology
Ranking neoantigens for escape-resilience rather than predicted immunogenicity: Associated changes in vaccine design.
2026
·
Michael E. Bryan
, Miles Weatherseed
, et al.
·
Journal of Clinical Oncology
Synthetic lethality–informed neoantigen prioritisation to support mechanism-specific therapeutic strategies across human cancers.
2026
·
Michael E. Bryan
, Om H. Gandhi
, et al.
·
Journal of Clinical Oncology
The use of combination palliative radiotherapy and single agent immunotherapy for the management of head and neck squamous carcinoma (HNSCC) in the UK
2026
·
Chris Hurt
, Sarah Park
, et al.
·
Radiotherapy and Oncology
A Survey of Oncologists’ Perceptions and Opinions Regarding Brain Imaging in Metastatic Renal Cell Carcinoma Within the UK
2026
·
Ben T Crosby
, Emmanuel Eloebhose
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
11
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type